Alzheimer's Disease Neuroimaging Initiative 4 (ADNI4): In-Clinic Cohort
J
Jared Brosch, MD
Primary Investigator
Enrolling By Invitation
55-90 years
All
Phase
N/A
25 participants needed
1 Location
Brief description of study
The primary objectives of this study include:
•Validation of biomarker measures
• Inform clinical trial design
• Increased inclusion of underrepresented populations (URPs) to improve
generalizability of results and advance our understanding of health disparities
across URPs.
• Utility of web-based cognitive testing and blood-based biomarkers to remotely
identify and monitor those with AD biomarker pathology
• Longitudinal changes in cognition and associated biomarkers
• Prediction of cognitive decline
• Discovery of novel risk and protective genes and pathways, and other known
disease proteins found in AD brains.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Alzheimer's disease
-
Age: Between 55 Years - 90 Years
-
Gender: All
Inclusion Criteria:
- Men and women aged 55-90 years across Cognitively Normal (CN), Mild Cognitive Impairment (MCI), and Dementia (DEM) populations
Other inclusion and exclusion criteria may apply. Contact study team for more details.
Updated on
01 Aug 2024.
Study ID: NEUR-USC-ADNI4, 17410
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
